24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Belviq
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:28
Gilad Altshuler: Nasdaq will keep climbing as new technologies emerge
12:10
Code Blue appoints Shelly Shlomo Brownshtein as VP of Client Experience and Resources
10:44
Intel settles case with Jewish ex-employee who alleged antisemitic retaliation
09:19
Aleph Farms raised $140 million—but now it's struggling to survive
More stories
Buzz
Most popular
Daily
Weekly
1
AI won’t replace developers—but it will change who gets hired
2
‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens
3
Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift
4
Tel Aviv real estate reaches new peak at over $45,000 per sqm
5
Yad2 now valued at $420 million as investors line up for potential sale
More news
Belviq
1 stories about Belviq
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
16.02.20
|
Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%